Rare disease benchmarks: Investment professionals’ accuracy and beliefs
Drug Discovery Today · 2026
DOI: 10.1016/j.drudis.2026.104792 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Discovery Today, 2026. Verfasst von Jonathan Ilicki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Industrifonden, Box 1163, 111 91 Stockholm, Sweden. Electronic address: j.ilicki@gmail.com. Hauptthemen laut MEDLINE: Rare Diseases, Benchmarking, Drug Industry, Investments. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Industrifonden, Box 1163, 111 91 Stockholm, Sweden. Electronic address: j.ilicki@gmail.com.
- SERB Pharmaceuticals, Unit 1005, Cannon Green, 27 Bush Ln, London EC4R 0AA, UK.
Zitieren
APA
Ilicki, J., & Spicer, A. J. (2026). Rare disease benchmarks: Investment professionals’ accuracy and beliefs. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104792
Vancouver
Ilicki J, Spicer AJ. Rare disease benchmarks: Investment professionals’ accuracy and beliefs. Drug Discovery Today. 2026. doi:10.1016/j.drudis.2026.104792
BibTeX
@article{Ilicki2026,
author = {Ilicki, Jonathan and Spicer, Alexander J},
title = {Rare disease benchmarks: Investment professionals’ accuracy and beliefs},
journal = {Drug Discovery Today},
year = {2026},
doi = {10.1016/j.drudis.2026.104792}
}
EUVIMED